Serial Number
88436195
Owner
NEUMORA THERAPEUTICS, INC.Attorney
Adam SikichFiling Date
May 17, 2019
Serial #88436195 Trademark
Serial Number: 88436195
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Owner Contact Info
8000 MARINA BLVD, SUITE 700
BRISBANE, CA 94005
Entity Type: 03
329 Oyster Point Blvd, 3rd Floor
South San Francisco, CA 94080
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
May 17, 2019
Registration Date
Not Registered
Published for Opposition
March 31, 2020
Goods & Services
Providing a website featuring non-downloadable publications in the nature of questionnaires and assessment forms for screening and diagnosing a patient's psychological condition and recommending treatments and drug development
Downloadable mobile application software for administering questionnaires, administering tasks, capturing users' facial video and speech recordings, screening and diagnosing a patient's psychological condition and recommending treatments and drug development for mental health wellness and the management of neurobehavioral health
Health care services, namely, psychological or neurological testing by means of questionnaires, tests, and assessments relating to a patient's mental health, including for screening and diagnosing a patient's psychological or neurological condition and recommending treatments and drug development
Providing online, non-downloadable computer software for administering questionnaires, tests, and assessments relating to a patient's mental health, including for screening and diagnosing a patient's psychological condition and recommending treatments and drug development